# Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer

> **NCT07632365** · PHASE1,PHASE2 · RECRUITING · sponsor: **Shanghai Chest Hospital** · enrollment: 108 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Locally Advanced Non-Small Cell Lung Cancer
- Unresectable Stage III NSCLC

## Interventions

- **DRUG:** Induction chemoimmunotherapy
- **RADIATION:** Concurrent chemoradiotherapy (cCRT)
- **DRUG:** consolidation immunotherapy

## Key facts

- **NCT ID:** NCT07632365
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-09
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07632365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07632365, "Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07632365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*